Loading...

Vivos Therapeutics, Inc.

VVOSNASDAQ
Healthcare
Medical - Devices
$7.12
$1.12(18.67%)

Vivos Therapeutics, Inc. (VVOS) Company Profile & Overview

Explore Vivos Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Vivos Therapeutics, Inc. (VVOS) Company Profile & Overview

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

SectorHealthcare
IndustryMedical - Devices
CEOR. Kirk Huntsman

Contact Information

866 908 4867
9137 Ridgeline Boulevard, Highlands Ranch, CO, 80129

Company Facts

109 Employees
IPO DateDec 11, 2020
CountryUS
Actively Trading

Frequently Asked Questions

;